價(jià)格 | ¥6990 | ¥3730 |
包裝 | 10mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:化合物 PF-06649298 | 英文名稱:PF-06649298 |
CAS:1854061-16-7 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T60629 |
Name | PF-06649298 |
Description | PF-06649298 is an inhibitor of sodium-coupled citrate transporter which specifically interacts with NaCT with an IC 50 value of 16.2 μM to inhibits the transport of citrate in human hepatocytes. PF-06649298 can be used in regulating metabolism of glucose and metabolism of lipid [1] [2]. |
In vitro | PF-06649298 (0-100 μM; 30 min) inhibits citrate uptaken in cells [2]. Cell Viability Assay [1] Cell Line: HEK-293 cells expressing NaCT, NaDC1 or NaDC3, human hepatocytes and mouse epatocytes Concentration: 0-100 μM Incubation Time: 30 min Result: Showed a selectivity for NaCT over the dicarboxylate transporters NaDC1 and NaDC3. Inhibited citrate uptake in HEK-293 cells expressing NaCT, NaDC1 or NaDC3, human hepatocytes and mouse epatocytes with IC 50 s of 408 nM, >100 μM, >100 μM, 16.2 μM and 4.5 μM, respectively. |
In vivo | PF-06649298 (250 mg/kg; p.o. twice a day; for 21 days) reverses glucose intolerance of HFD mice [1]. Animal Model: Mice with HFD administration [2] Dosage: 250 mg/kg Administration: Oral gavage; 250mg/kg twice a day; for 21 days Result: Decreased plasma glucose, hepatic triglycerides, diacylglycerides, and acyl-carnitines concentration of livers in HFD mice. Totally reversed glucose intolerance of HFD mice. |
Storage | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP2年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-07-24 | |
詢價(jià) |
VIP3年
|
武漢英諾醫(yī)藥科技有限公司
|
2025-02-03 | |
¥20 |
VIP5年
|
杭州固拓生物科技有限公司
|
2025-01-24 |